Page last updated: 2024-09-04

abiraterone and Chromosomal Instability

abiraterone has been researched along with Chromosomal Instability in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Anand, M; Antonarakis, ES; Armstrong, AJ; Barnett, ES; Berry, WR; Brown, LC; Carbone, EA; Danila, DC; George, DJ; Giannakakou, P; Gill, A; Gregory, SG; Gupta, S; Halabi, S; Healy, P; Jendrisak, A; Luo, J; Nanus, DM; Scher, HI; Schonhoft, JD; Szmulewitz, RZ; Wenstrup, R; Yang, Q; Zhao, JL1

Other Studies

1 other study(ies) available for abiraterone and Chromosomal Instability

ArticleYear
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 07-15, Volume: 27, Issue:14

    Topics: Adult; Aged; Aged, 80 and over; Androstenes; Benzamides; Chromosomal Instability; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Neurosecretory Systems; Nitriles; Phenotype; Phenylthiohydantoin; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome

2021